While small interfering RNAs (siRNAs) are commonly used for laboratory studies, development of siRNA therapeutics has been slower than expected, due, in part, to a still limited understanding of the endocytosis and intracellular trafficking of siRNA-containing complexes. With the recent characterization of multiple clathrin-/caveolin-independent endocytic pathways, that is, those mediated by Graf1, Arf6, and flotillin, it has become clear that the endocytic mechanism influences subsequent intracellular processing of the internalized cargo. To explore siRNA delivery in light of these findings, we developed a novel assay that differentiates uptake by each of the endocytic pathways and can be used to determine whether endocytosis by a pathway leads to the initiation of RNA interference (RNAi). Using Lipofectamine 2000 (LF2K), we determined the endocytosis pathway leading to active silencing (whether by clathrin, caveolin, Arf6, Graf1, flotillin, or macropinocytosis) across multiple cell types (HeLa, H1299, HEK293, and HepG2). We showed that LF2K is internalized by Graf1-, Arf6-, or flotillin-mediated endocytosis for the initiation of RNAi, depending on cell type. In addition, we found that a portion of siRNA-containing complexes is internalized by pathways that do not lead to initiation of silencing. Inhibition of these pathways enhanced intracellular levels of siRNAs with concomitant enhancement of silencing.
Get full access to this article
View all access options for this article.
References
1.
BurnettJC and RossiJJ. (2012). RNA-based therapeutics: current progress and future prospects. Chem Biol, 19:60–71.
2.
AngartP, VocelleD, ChanC and WaltonSP. (2013). Design of siRNA therapeutics from the molecular scale. Pharmaceuticals, 6:440–468.
3.
SakuraiK, AmarzguiouiM, KimD-H, AlluinJ, HealeB, SongM, GatignolA, BehlkeM and RossiJJ. (2011). A role for human dicer in pre-RISC loading of siRNAs. Nucleic Acids Res, 39:1510–1525.
4.
TomariY, MatrangaC, HaleyB, MartinezN and ZamorePD. (2004). A protein sensor for siRNA asymmetry. Science, 306:1377–1380.
5.
MacRaeIJ, MaE, ZhouM, RobinsonCV and DoudnaJA. (2008). In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci U S A, 105:512–517.
6.
GredellJA, DittmerMJ, WuM, ChanC and WaltonSP. (2010). Recognition of siRNA asymmetry by TAR RNA binding protein. Biochemistry, 49:3148–3155.
7.
NolandCL, MaE and DoudnaJA. (2011). siRNA repositioning for guide strand selection by human dicer complexes. Mol Cell, 43:110–121.
8.
YinH, KanastyRL, EltoukhyAA, VegasAJ, DorkinJR and AndersonDG. (2014). Non-viral vectors for gene-based therapy. Nat Rev Genet, 15:541–555.
9.
GarberK. (2018). Alnylam launches era of RNAi drugs. Nat Biotechnol, 36:777–778.
10.
SpringerAD and DowdySF. (2018). GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics. Nucleic Acid Ther, 28:109–118.
11.
KnudsenKB, NorthevedH, KumarPE, PerminA, GjettingT, AndresenTL, LarsenS, WegenerKM, LykkesfeldtJ, et al. (2015). In vivo toxicity of cationic micelles and liposomes. Nanomedicine, 11:467–477.
12.
MutluGM, BudingerGRS, GreenAA, UrichD, SoberanesS, ChiarellaSE, AlheidGF, McCrimmonDR, SzleiferI and HersamMC. (2010). Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett, 10:1664–1670.
13.
MoghimiSM, HunterAC and AndresenTL. (2012). Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol, 52:481–503.
14.
MalefytAP, WaltonSP and ChanC. (2012). Endocytosis pathways for nucleic acid therapeutics. Nano Life, 2:1241005.
15.
GlebovOO, BrightNA and NicholsBJ. (2006). Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol, 8:46–54.
16.
RadhakrishnaH and DonaldsonJG. (1997). ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. J Cell Biol, 139:49–61.
17.
LundmarkR, DohertyGJ, HowesMT, CorteseK, VallisY, PartonRG and McMahonHT. (2008). The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr Biol, 18:1802–1808.
18.
DohertyGJ and McMahonHT. (2009). Mechanisms of endocytosis. Annu Rev Biochem, 78:857–902.
19.
SandvigK, PustS, SkotlandT and van DeursB. (2011). Clathrin-independent endocytosis: mechanisms and function. Curr Opin Cell Biol, 23:413–420.
20.
El-SayedA and HarashimaH. (2013). Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol Ther, 21:1118–1130.
21.
NonnenmacherM and WeberT. (2011). Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe, 10:563–576.
22.
ElkinSR, LakodukAM and SchmidSL. (2016). Endocytic pathways and endosomal trafficking: a primer. Wien Med Wochenschr, 166:196–204.
23.
JulianoRL. (2018). Intracellular trafficking and endosomal release of oligonucleotides: what we know and what we don't. Nucleic Acid Ther, 28:166–177.
24.
LiuX, HowardKA, DongM, AndersenMØ, RahbekUL, JohnsenMG, HansenOC, BesenbacherF and KjemsJ. (2007). The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials, 28:1280–1288.
25.
KaufmanWL, KocmanI, AgrawalV, RahnH-P, BesserD and GossenM. (2008). Homogeneity and persistence of transgene expression by omitting antibiotic selection in cell line isolation. Nucleic Acids Res, 36:e111.
26.
RappoportJZ, TahaBW, LemeerS, BenmerahA and SimonSM. (2003). The AP-2 complex is excluded from the dynamic population of plasma membrane-associated clathrin. J Biol Chem, 278:47357–47360.
27.
GaidarovI, SantiniF, WarrenRA and KeenJH. (1999). Spatial control of coated-pit dynamics in living cells. Nat Cell Biol, 1:1–7.
28.
ForkC, HitzelJ, NicholsBJ, TikkanenR and BrandesRP. (2014). Flotillin-1 facilitates Toll-like receptor 3 signaling in human endothelial cells. Basic Res Cardiol, 109:439.
29.
SmartEJ and AndersonRGW. (2002). Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol, 353:131–139.
30.
CooperJA. (1987). Effects of cytochalasin and phalloidin on actin. J Cell Biol, 105:1473–1478.
31.
LanghorstMF, SolisGP, HannbeckS, PlattnerH and StuermerCAO. (2007). Linking membrane microdomains to the cytoskeleton: regulation of the lateral mobility of reggie-1/flotillin-2 by interaction with actin. FEBS Lett, 581:4697–4703.
32.
SolisGP, HülsbuschN, RadonY, KatanaevVL, PlattnerH and StuermerCAO. (2013). Reggies/flotillins interact with Rab11a and SNX4 at the tubulovesicular recycling compartment and function in transferrin receptor and E-cadherin trafficking. Mol Biol Cell, 24:2689–2702.
33.
MaciaE, EhrlichM, MassolR, BoucrotE, BrunnerC and KirchhausenT. (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell, 10:839–850.
34.
SandvigK, TorgersenML, RaaHA and DeursB. (2008). Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity. Histochem Cell Biol, 129:267–276.
35.
KleymanTR and CragoeEJ. (1988). Amiloride and its analogs as tools in the study of ion transport. J Membr Biol, 105:1–21.
36.
YaoD, EhrlichM, HenisYI and LeofEB. (2002). Transforming growth factor-β receptors interact with AP2 by direct binding to B2 subunit. Mol Biol Cell, 13:4001–4012.
37.
PortisAM, CarballoG, BakerGL, ChanC and WaltonSP. (2010). Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles. Microsc Res Tech, 73:878–885.
38.
MalefytAP, WuM, VocelleDB, KappesSJ, LindemanSD, ChanC and WaltonSP. (2014). Improved asymmetry prediction for short interfering RNAs. FEBS J, 281:320–330.
39.
VocelleD, ChesniakOM, MalefytAP, ComiskeyG, Adu-BerchieK, SmithMR, ChanC and WaltonSP. (2016). Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing. Technology (Singap World Sci). 4:42–54.
40.
DalbyB, CatesS, HarrisA, OhkiEC, TilkinsML, PricePJ and CiccaroneVC. (2004). Advanced transfection with lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods, 33:95–103.
41.
CuiS, ZhangS, ChenH, WangB, ZhaoY and ZhiD. (2012). The mechanism of lipofectamine 2000 mediated transmembrane gene delivery. Engineering, 4:172–175.
42.
LazebnikM, KeswaniRK and PackDW. (2016). Endocytic transport of polyplex and lipoplex siRNA vectors in HeLa cells. Pharm Res, 33:2999–3011.
43.
PichonC, BillietL and MidouxP. (2010). Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotechnol, 21:640–645.
44.
BillietL, GomezJP, BerchelM, JaffrèsPA, Le GallT, MontierT, BertrandE, CheradameH, GuéganP, et al. (2012). Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line. Biomaterials, 33:2980–2990.
45.
MingX, SatoK and JulianoRL. (2011). Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes. J Control Release, 153:83–92.
46.
VercauterenD, VandenbrouckeRE, JonesAT, RejmanJ, DemeesterJ, De SmedtSC, SandersNN and BraeckmansK. (2010). The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther, 18:561–569.
47.
IvanovAI. (2008) Exocytosis and endocytosis. Methods Mol Biol, 440:15–33.
48.
RodalSK, SkrettingG, GarredØ, VilhardtF, van DeursB and SandvigK. (1999). Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell, 10:961–974.
49.
MilhaudJ. (1992). Permeabilizing action of filipin III on model membranes through a filipin-phospholipid binding. Biochim Biophys Acta, 1105:307–318.
50.
LiHH, LiJ, WasserloosKJ, WallaceC, SullivanMG, BauerPM, StolzDB, LeeJS, WatkinsSC, et al. (2013). Caveolae-dependent and -independent uptake of albumin in cultured rodent pulmonary endothelial cells. PLoS One, 8:1–12.
51.
ElkinSR, BendrisN, ReisCR, ZhouY, XieY, HuffmanKE, MinnaJD and SchmidSL. (2015). A systematic analysis reveals heterogeneous changes in the endocytic activities of cancer cells. Cancer Res, 75:4640–4650.
52.
SaslowskyDE, ChoJA, ChinnapenH, MassolRH, ChinnapenDJF, WagnerJS, De LucaHE, KamW, PawBH and LencerWI. (2010). Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not derlin-1 or -2. J Clin Invest, 120:4399–4409.
53.
NaslavskyN, WeigertR and DonaldsonJG. (2003). Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol Biol Cell, 14:417–431.
54.
HowesMT, KirkhamM, RichesJ, CorteseK, WalserPJ, SimpsonF, HillMM, JonesA, LundmarkR, et al. (2010). Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J Cell Biol, 190:675–691.
VarkouhiAK, ScholteM, StormG and HaismaHJ. (2011). Endosomal escape pathways for delivery of biologicals. J Control Release, 151:220–228.
57.
dos SantosT, VarelaJ, LynchI, SalvatiA and DawsonKA. (2011). Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One, 6:e24438.
58.
GuoZ, LiS, WangC, XuJ, KirkB, WuJ, LiuZ and XueW. (2017). Biocompatibility and cellular uptake mechanisms of poly(N-isopropylacrylamide) in different cells. J Bioact Compat Polym, 32:17–31.
59.
Al SorajM, HeL, PeynshaertK, CousaertJ, VercauterenD, BraeckmansK, De SmedtSC and JonesAT. (2012). siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-tat. J Control Release, 161:132–141.
60.
MillerCM, TanowitzM, DonnerAJ, PrakashTP, SwayzeEE, HarrisEN and SethPP. (2018). Receptor-mediated uptake of phosphorothioate antisense oligonucleotides in different cell types of the liver. Nucleic Acid Ther, 28:119–127.
61.
RientoK, FrickM, SchaferI and NicholsBJ. (2009). Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. J Cell Sci, 122:912–918.
62.
KasperJ, HermannsMI, BantzC, KoshkinaO, LangT, MaskosM, PohlC, UngerRE and KirkpatrickCJ. (2013). Interactions of silica nanoparticles with lung epithelial cells and the association to flotillins. Arch Toxicol, 87:1053–1065.
63.
VercauterenD, PiestM, van der AaLJ, Al SorajM, JonesAT, EngbersenJFJ, De SmedtSC and BraeckmansK. (2011). Flotillin-dependent endocytosis and a phagocytosis-like mechanism for cellular internalization of disulfide-based poly(amido amine)/DNA polyplexes. Biomaterials, 32:3072–3084.
64.
OttoGP and NicholsBJ. (2011). The roles of flotillin microdomains—endocytosis and beyond. J Cell Sci, 124:3933–3940.
65.
ArkhipovaKA, SheydermanAN, LaktionovKK, MochalnikovaVV and ZborovskayaIB. (2014). Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas. BMC Cancer, 14:100.
66.
LisantiMP, LodishHF, SchnitzerJE, OhP, SchererPE and BickelPE. (2002). Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem, 272:13793–13802.
67.
FrancisMK, HolstMR, Vidal-QuadrasM, HenrikssonS, Santarella-MellwigR, SandbladL and LundmarkR. (2015). Endocytic membrane turnover at the leading edge is driven by a transient interaction between Cdc42 and GRAF1. J Cell Sci, 128:4183–4195.
68.
UrrutiaR, HenleyJR, CookT and McNivenMA. (1997). The dynamins: redundant or distinct functions for an expanding family of related GTPases?. Proc Natl Acad Sci U S A, 94:377–384.
69.
DonaldsonJG. (2003). Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem, 278:41573–41576.
70.
NaslavskyN, WeigertR and DonaldsonJG. (2004). Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol Biol Cell, 15:3542–3552.
71.
BrownFD, RozelleAL, YinHL, BallaT and DonaldsonJG. (2001). Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol, 154:1007–1018.
72.
NishiK and SaigoK. (2007). Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6. J Biol Chem, 282:27503–27517.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
